The fentanyl crisis has become a major sticking point in trade talks between the United States and China. The synthetic opioid, known for its extreme potency, is tied to a sharp rise in overdose deaths across the U.S.
American officials have pointed to China’s role in the production and export of fentanyl and its chemical precursors. They claim this has fueled the epidemic in U.S. communities.
In response, the U.S. imposed a 20% tariff, often called the “fentanyl tariff.” This measure aims to discourage imports linked to the drug trade. However, it has added strain to already complex trade negotiations.
China rejects the blame. Chinese authorities argue that the crisis is driven mainly by domestic issues within the United States. Despite this, they have moved to tighten regulations on certain precursor chemicals.
Still, the disagreement remains unresolved. It reflects deeper issues in US-China relations, where public health concerns now collide with trade and diplomatic tensions.
For more in-depth coverage and updates on this developing story, visit The Economic Times.
